Study: CAR-T cell Therapy Evaluated for Refractory Diffuse Large B-Cell Lymphoma
4 Jan, 2019 | 20:28h | UTCTisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma – University of Chicago Medical Center (free)